{"database": "lobbying", "table": "lobbying_activities", "rows": [[2546208, "7209a858-6b08-4506-9162-6636e78d6c6b", "Q4", "BLOOM STRATEGIC COUNSEL", 401036920, "FRESENIUS MEDICAL CARE NORTH AMERICA", 2020, "fourth_quarter", "LBR", "Competition issues in the kidney dialysis market", "HOUSE OF REPRESENTATIVES,SENATE", 20000, null, 0, 0, "2021-01-04T14:30:50.103000-05:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["2546208"], "units": {}, "query_ms": 183.20785998366773, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}